Symmetric Arginine Dimethylation Is Selectively Required for mRNA Splicing and the Initiation of Type I and Type III Interferon Signaling.
Saved in:
| Title: | Symmetric Arginine Dimethylation Is Selectively Required for mRNA Splicing and the Initiation of Type I and Type III Interferon Signaling. |
|---|---|
| Authors: | Metz PJ; Tumor Cell Biology, Pfizer Oncology Research & Development, La Jolla, Pfizer Inc., 10777 Science Center Drive, San Diego, CA 92121, USA. Electronic address: patrick.metz@pfizer.com., Ching KA; Computational Biology, Pfizer Oncology Research & Development, La Jolla, Pfizer Inc., 10777 Science Center Drive, San Diego, CA 92121, USA., Xie T; Computational Biology, Pfizer Oncology Research & Development, La Jolla, Pfizer Inc., 10777 Science Center Drive, San Diego, CA 92121, USA., Delgado Cuenca P; Tumor Cell Biology, Pfizer Oncology Research & Development, La Jolla, Pfizer Inc., 10777 Science Center Drive, San Diego, CA 92121, USA., Niessen S; Tumor Cell Biology, Pfizer Oncology Research & Development, La Jolla, Pfizer Inc., 10777 Science Center Drive, San Diego, CA 92121, USA., Tatlock JH; Worldwide Medicinal Chemistry, Pfizer Oncology Research & Development, La Jolla, Pfizer Inc., 10777 Science Center Drive, San Diego, CA 92121, USA., Jensen-Pergakes K; Tumor Cell Biology, Pfizer Oncology Research & Development, La Jolla, Pfizer Inc., 10777 Science Center Drive, San Diego, CA 92121, USA., Murray BW; Tumor Cell Biology, Pfizer Oncology Research & Development, La Jolla, Pfizer Inc., 10777 Science Center Drive, San Diego, CA 92121, USA. |
| Source: | Cell reports [Cell Rep] 2020 Feb 11; Vol. 30 (6), pp. 1935-1950.e8. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 32049022 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Symmetric Arginine Dimethylation Is Selectively Required for mRNA Splicing and the Initiation of Type I and Type III Interferon Signaling. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Metz+PJ%22">Metz PJ</searchLink>; Tumor Cell Biology, Pfizer Oncology Research & Development, La Jolla, Pfizer Inc., 10777 Science Center Drive, San Diego, CA 92121, USA. Electronic address: patrick.metz@pfizer.com.<br /><searchLink fieldCode="AU" term="%22Ching+KA%22">Ching KA</searchLink>; Computational Biology, Pfizer Oncology Research & Development, La Jolla, Pfizer Inc., 10777 Science Center Drive, San Diego, CA 92121, USA.<br /><searchLink fieldCode="AU" term="%22Xie+T%22">Xie T</searchLink>; Computational Biology, Pfizer Oncology Research & Development, La Jolla, Pfizer Inc., 10777 Science Center Drive, San Diego, CA 92121, USA.<br /><searchLink fieldCode="AU" term="%22Delgado+Cuenca+P%22">Delgado Cuenca P</searchLink>; Tumor Cell Biology, Pfizer Oncology Research & Development, La Jolla, Pfizer Inc., 10777 Science Center Drive, San Diego, CA 92121, USA.<br /><searchLink fieldCode="AU" term="%22Niessen+S%22">Niessen S</searchLink>; Tumor Cell Biology, Pfizer Oncology Research & Development, La Jolla, Pfizer Inc., 10777 Science Center Drive, San Diego, CA 92121, USA.<br /><searchLink fieldCode="AU" term="%22Tatlock+JH%22">Tatlock JH</searchLink>; Worldwide Medicinal Chemistry, Pfizer Oncology Research & Development, La Jolla, Pfizer Inc., 10777 Science Center Drive, San Diego, CA 92121, USA.<br /><searchLink fieldCode="AU" term="%22Jensen-Pergakes+K%22">Jensen-Pergakes K</searchLink>; Tumor Cell Biology, Pfizer Oncology Research & Development, La Jolla, Pfizer Inc., 10777 Science Center Drive, San Diego, CA 92121, USA.<br /><searchLink fieldCode="AU" term="%22Murray+BW%22">Murray BW</searchLink>; Tumor Cell Biology, Pfizer Oncology Research & Development, La Jolla, Pfizer Inc., 10777 Science Center Drive, San Diego, CA 92121, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101573691%22">Cell reports</searchLink> [Cell Rep] 2020 Feb 11; Vol. 30 (6), pp. 1935-1950.e8. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101573691 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2211-1247 (Electronic) <i>NLM ISO Abbreviation: </i>Cell Rep <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32049022 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.celrep.2020.01.054 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1935 Titles: – TitleFull: Symmetric Arginine Dimethylation Is Selectively Required for mRNA Splicing and the Initiation of Type I and Type III Interferon Signaling. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Metz PJ – PersonEntity: Name: NameFull: Ching KA – PersonEntity: Name: NameFull: Xie T – PersonEntity: Name: NameFull: Delgado Cuenca P – PersonEntity: Name: NameFull: Niessen S – PersonEntity: Name: NameFull: Tatlock JH – PersonEntity: Name: NameFull: Jensen-Pergakes K – PersonEntity: Name: NameFull: Murray BW IsPartOfRelationships: – BibEntity: Dates: – D: 11 M: 02 Text: 2020 Feb 11 Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 2211-1247 Numbering: – Type: volume Value: 30 – Type: issue Value: 6 Titles: – TitleFull: Cell reports Type: main |
| ResultId | 1 |
